ZEALAND PHARMA A/S ZLDPF
ZEALAND PHARMA A/S ZLDPF
- USD (-)
- Temps différé 15min - NASDAQ OTCBB
Ouverture: -
Variation: -
Volume: -
+ Bas: -
+ Haut: -
Ecart + Bas / + Haut: -
Type: Actions
Ticker: ZLDPF
ISIN: DK0060257814

Correction: Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

  • 72

Company announcement – No. 13 / 2020

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Copenhagen, March 31, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78) has received information on transactions in Zealand's shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons and hereby publishes the information on such transactions.

Please see the attached file.

April 1, 2020 update: referenced file now attached.

 

For further information, please contact:

Zealand Pharma Investor Relations
+45 50 60 38 00 [email protected]

Lani Pollworth Morvan, Investor Relations and Communication
[email protected]

About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen and New York: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of innovative peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Zealand’s portfolio also includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals.

Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or follow Zealand on LinkedIn or Twitter @ZealandPharma.  

 

Attachments

ti?nf=MTAwMDMyODU2MyM0MDA2NDU3NzEjMjAwMTcwMQ==

Primary Logo

GlobeNewsWire
GlobeNewsWire

GlobeNewswire est l'un des plus grands réseaux de distribution de nouvelles au monde, spécialisé dans la diffusion de communiqués de presse, d'informations financières et de contenus multimédias aux investisseurs, médias, et lecteurs du monde entier.